Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports
Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports buy - large image1
Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports buy - image1
Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports buy - image2
Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports buy - image3
Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports buy - image4
Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports buy - image5
Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports buy - image6

Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports

TDS 6843 Inquiries

Unit Price:

$75-89/UNIT EXW

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

hebei

Brand:

SDR

Packaging:

Bottled

Price valid (until):

2027-10-26

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Introduction  


    Items Specifications
    Packaging method Bottled
    Purity 99%
    Product abbreviation RT
    Dosage 40mg*10vials

     Retatrutide (RT) is mainly used to help with significant weight loss and is used in the treatment of type 2 diabetes (but currently mainly focuses on obesity treatment). Its principle is similar to that of Tirzepatide, but it increases the activation of the glucagon receptor, which can: To boost energy expenditure and promote stronger weight loss, in simple terms: Retatrutide is an "upgraded version" of Tirzepatide, enhancing the effect of the Glucagon receptor, with the goal of achieving a stronger weight loss effect


      Company Profile


    We are a high-tech enterprise dedicated to the research and development of innovative peptide compounds, customized synthesis and supply of scientific research raw materials. We are deeply involved in the fields of peptide chemical synthesis, purification processes and quality analysis, providing high-quality peptide research raw materials and technical support services to domestic and foreign university laboratories, pharmaceutical research institutions and CRO enterprises.
    The company has gathered professional technical teams specializing in peptide synthesis, analysis and testing, and process development. It has established a complete peptide synthesis laboratory, purification platform and quality control testing system, and possesses the capacity for large-scale preparation of long-chain peptides, modified peptides and novel target peptides. It can provide integrated technical support including solid-phase synthesis, liquid-phase synthesis, chromatographic purification, structural characterization and stability research.
    The core scientific research raw material product line covers GLP-1-related target peptides and various innovative active peptide intermediates, among which Retatrutide (LY3437943) is a scientific research grade peptide raw material. All products are for in vitro scientific research and experimental use only. They must not be used for human trials, clinical drug administration, medical aesthetics or any diagnostic or therapeutic purposes.
    The company has established a standardized quality control process. Each batch of raw materials is accompanied by HPLC purity testing and MS mass spectrometry structure verification reports, strictly controlling key indicators such as purity, impurities, and moisture. We can provide services such as repackaging in different specifications, customized synthesis, and process optimization, supporting the experimental needs of research institutions for the early-stage pharmacological research and mechanism exploration of new drug targets.
    Since its establishment, the enterprise has adhered to the concept of compliant operation, strictly abided by relevant laws and regulations on pharmaceutical research and development, and established long-term and stable cooperation with many domestic universities and drug research and development laboratories. With stable product quality, efficient delivery capabilities and professional technical consulting services, we support the basic research of innovative metabolic target drugs and continuously provide reliable raw material support for global peptide basic scientific research.


    Business philosophy


    Focus on the innovative research and development of peptides, strictly adhere to the boundaries of scientific research and application, prioritize quality, and achieve win-win results through integrity

    Contact information





    Email: 1060575270@qq.com

    W hatsapp:+852 5976 3637


      Product display 


    Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 1 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 2 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 3 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 4 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 5 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 6 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 7 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 8 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 9 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 10  Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 11 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 12 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 13 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 14 Shop Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports-Detailed Image 15


    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Certificates
    • Avoid Sourcing Risks: Genuine Retatrutide 40mg*10vials Triple Agonist with HPLC & LC-MS Test Reports Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

    Location:

    Units 1503-14, 15th Floor, New HNA Building, No. 7 Guoxing Avenue, Lantian Subdistrict, Meilan District, Haikou City, Hainan Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    101-200

    Year of Establishment:

    2025

  • Inquiry History
    6843 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.